Use the Back button in your browser to see the other results of your search or to select another record.
Cost-effectiveness of physical activity counselling in general practice |
Elley CR, Kerse N, Arroll B, Swinburn B, Ashton T, Robinson E |
New Zealand Medical Journal 2004 Dec 17;117(1207):U1216 |
clinical trial |
5/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: No; Intention-to-treat analysis: Yes; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
AIM: To assess the cost-effectiveness of the 'Green Prescription' physical activity counselling programme in general practice. METHOD: Prospective cost-effectiveness study undertaken as part of a cluster randomised controlled trial with 12-month follow-up of 878 'less-active' patients aged 40 to 79 years in 42 general practices in the Waikato. The intervention was verbal advice and a written exercise prescription given by general practitioners, with telephone exercise specialist follow-up compared with usual care. Main outcome measures included cost per total and leisure-time physical activity gain from health-funders' and societal perspectives. RESULTS: Significant increases in physical activity were found in the randomised controlled trial. Programme-cost per patient was NZ$170 from a funder's perspective. The monthly cost-effectiveness ratio for total energy expenditure achieved was $11 per kcal/kg/day. The incremental cost of converting one additional 'sedentary' adult to an 'active' state over a twelve-month period was NZ$1,756 in programme costs. CONCLUSION: Verbal and written physical activity advice given in general practice with telephone follow-up is an inexpensive way of increasing activity for sedentary people, and has the potential to have significant economic impact through reduction in cardiovascular and other morbidity and mortality.
|